Literature DB >> 10687873

Anti-inflammatory effects of fangchinoline and tetrandrine.

H S Choi1, H S Kim, K R Min, Y Kim, H K Lim, Y K Chang, M W Chung.   

Abstract

Fangchinoline and tetrandrine are the major alkaloids from Stephania tetrandrae S. Moore which has been used traditionally for the treatment of inflammatory diseases in oriental countries including Korea. Both fangchinoline and tetrandrine showed anti-inflammatory effects on mouse ear edema induced by croton oil. In addition, the effects of fangchinoline and tetrandrine on cyclooxygenase, murine interleukin-5 (mIL-5) and human interleukin-6 (hIL-6) were examined in vitro to investigate the anti-inflammatory action mechanisms. One hundred micromolar of fangchinoline showed 35% of inhibition on cyclooxygenase, but the same concentration of tetrandrine did not show any inhibition. On the other hand, 12.5 microM of tetrandrine exhibited 95% of inhibition on mIL-5 activity, while fangchinoline did not show any effects. However, 4 microM of fangchinoline and 6 microM of tetrandrine showed 63 and 86% of inhibitions on hIL-6 activity, respectively. These results suggest that biochemical mechanisms of fangchinoline and tetrandrine on anti-inflammation are significantly different even though they are similar in chemical structure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10687873     DOI: 10.1016/s0378-8741(99)00141-5

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  32 in total

1.  Dihydroartemisinin inhibits cell proliferation via AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells.

Authors:  Kui Liao; Juan Li; Zhiling Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

2.  Tetrandrine ameliorates dextran-sulfate-sodium-induced colitis in mice through inhibition of nuclear factor -kappaB activation.

Authors:  Dei Kui Zhang; Li Na Cheng; Xiao Li Huang; Wei Shi; Jun Ying Xiang; Hua Tian Gan
Journal:  Int J Colorectal Dis       Date:  2008-08-07       Impact factor: 2.571

3.  Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents.

Authors:  Junrong Song; Junjie Lan; Chao Chen; Shengcao Hu; Jialei Song; Wulin Liu; Xueyi Zeng; Huayong Lou; Yaacov Ben-David; Weidong Pan
Journal:  Medchemcomm       Date:  2018-05-04       Impact factor: 3.597

4.  Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.

Authors:  Feng Tian; Ding Ding; Dandan Li
Journal:  Int J Oncol       Date:  2015-04-09       Impact factor: 5.650

5.  Anti-nociceptive, anti-inflammatory and toxicological evaluation of Fang-Ji-Huang-Qi-Tang in rodents.

Authors:  Yu-Chin Lin; Ching-Wen Chang; Chi-Rei Wu
Journal:  BMC Complement Altern Med       Date:  2015-02-05       Impact factor: 3.659

6.  Protective Effect of Tetrandrine in a Rabbit Model of Osteoarthritis.

Authors:  Fengfeng Wu; Juntao Xu; Zaihua Zhu
Journal:  Arch Rheumatol       Date:  2017-09-13       Impact factor: 1.472

7.  Combination Nanotherapeutics for Dry Eye Disease Treatment in a Rabbit Model.

Authors:  Liandi Huang; Huanhuan Gao; Zhigang Wang; Yixin Zhong; Lan Hao; Zhiyu Du
Journal:  Int J Nanomedicine       Date:  2021-05-26

8.  Fangchinoline induces G0/G1 arrest by modulating the expression of CDKN1A and CCND2 in K562 human chronic myelogenous leukemia cells.

Authors:  Yuping Wang; Jie Chen; Lin Wang; Yuji Huang; Ye Leng; Guiying Wang
Journal:  Exp Ther Med       Date:  2013-01-24       Impact factor: 2.447

9.  Effect of fangchinoline on root resorption during rat orthodontic tooth movement.

Authors:  Xingfu Bao; Min Hu; Yi Zhang; Ferdinand Machibya; Ying Zhang; Huan Jiang; Dongsheng Yu
Journal:  Korean J Orthod       Date:  2012-06-28       Impact factor: 1.372

10.  Development and Validation of an UHPLC-QqQ-MS Technique for Simultaneous Determination of Ten Bioactive Components in Fangji Huangqi Tang.

Authors:  Xiaoli Wang; Xiao Liu; Tingting Zhu; Baochang Cai
Journal:  J Anal Methods Chem       Date:  2016-05-26       Impact factor: 2.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.